MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
IRIDEX Corporation DSO Ratio 2011-2026 | IRIX
Annual DSO Ratio IRIDEX Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45.6 | 43.3 | 36.6 | - | 78.3 | 77.8 | 69 | 81.1 | 71.1 | - | 70.1 | 59.1 | 45.6 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 81.1 | 36.6 | 61.6 |
Quarterly DSO Ratio IRIDEX Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52.1 | 46.5 | 48.4 | - | 48.1 | 46.2 | 51.4 | - | 44.5 | 47.4 | 43.8 | - | 40.4 | 45.9 | 48.8 | - | 58.9 | 57 | 31.2 | - | 61.5 | 93.7 | 82.5 | - | 79.8 | 81.6 | 79.3 | - | 73.2 | 80.4 | 81.3 | 70 | 66 | 71.7 | 77.8 | 73 | 93.5 | 76.8 | 70.2 | - | 70 | 77.5 | 33.9 | - | 66.9 | 60.3 | 62.2 | - | 70.4 | 72.8 | 65.5 | - | 63.5 | 59.2 | 60.6 | - | 61.3 | 62.6 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 93.7 | 31.2 | 63.3 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
40.7 | $ 2.2 | -0.45 % | $ 3.43 M |  USA |
 |
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.8 | $ 10.55 | 0.91 % | $ 1.43 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
43.1 | $ 12.94 | -0.84 % | $ 1.94 B | USA |
 |
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | USA |
 |
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
72 | $ 8.29 | -0.84 % | $ 595 M |  Israel |
 |
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | USA |
 |
ClearPoint Neuro
CLPT
|
55.6 | $ 9.69 | -13.17 % | $ 274 M | USA |
 |
Butterfly Network
BFLY
|
76.1 | $ 4.05 | -4.93 % | $ 857 M | USA |
 |
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
65.7 | $ 70.93 | -0.45 % | $ 105 B | USA |
 |
Cytosorbents Corporation
CTSO
|
68.6 | $ 0.66 | -2.96 % | $ 35.9 M | USA |
 |
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.96 | -2.28 % | $ 148 M |  France |
 |
CONMED Corporation
CNMD
|
64.5 | $ 37.07 | -0.3 % | $ 1.15 B | USA |
 |
Establishment Labs Holdings
ESTA
|
123 | $ 65.5 | 0.75 % | $ 1.94 B |  Costa-rica |
 |
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | USA |
 |
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
120 | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
237 | $ 18.45 | -0.03 % | $ 121 M | USA |
 |
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | USA |
 |
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | USA |
 |
Abbott Laboratories
ABT
|
61.2 | $ 108.88 | -1.69 % | $ 190 B | USA |
 |
InMode Ltd.
INMD
|
5.36 | $ 13.57 | -0.59 % | $ 877 M | Israel |
 |
Delcath Systems
DCTH
|
48.5 | $ 9.46 | -2.87 % | $ 339 M | USA |
 |
Bio-Rad Laboratories
BIO
|
66.9 | $ 269.22 | -0.06 % | $ 7.6 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 16.83 | -2.21 % | $ 395 M | USA |
 |
Helius Medical Technologies
HSDT
|
53.3 | $ 2.07 | -4.61 % | $ 1.26 M | USA |
 |
AxoGen
AXGN
|
40.7 | $ 30.96 | -5.48 % | $ 1.43 B | USA |
 |
Align Technology
ALGN
|
86.7 | $ 172.07 | -2.3 % | $ 12.9 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
60.3 | $ 8.89 | -2.31 % | $ 685 M | USA |
 |
Bruker Corporation
BRKR
|
57.3 | $ 34.23 | 1.45 % | $ 5.1 K | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
111 | $ 3.73 | -0.27 % | $ 153 M | USA |
 |
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
69.7 | $ 0.4 | 1.81 % | $ 41.1 M | USA |
 |
IRadimed Corporation
IRMD
|
52.7 | $ 101.27 | -1.49 % | $ 1.29 B | USA |